Press Releases
Ola Skanung new CFO at Cyxone, replacing Henrik Hang
31 Aug, 2022 15:00 CESTRegulatoryInterim Report 1 January to 30 June 2022
24 Aug, 2022 08:30 CESTRegulatoryCyxone files submission to start clinical Phase 2b study in Poland and Georgia
14 Jul, 2022 11:11 CESTCyxone receives pre-IND response from the US FDA regarding RA study
12 Jul, 2022 08:54 CESTCyxone files regulatory submission to start clinical phase 2b study with Rabeximod
23 Jun, 2022 12:23 CEST